Cantor Fitzgerald Has Weak Outlook for Amgen FY2025 Earnings
Amgen Inc. (NASDAQ:AMGN – Free Report) – Research analysts at Cantor Fitzgerald reduced their FY2025 earnings estimates for Amgen in a research note issued to investors on Wednesday, February 5th. Cantor Fitzgerald analyst O. Brayer now forecasts that the medical research company will earn $20.67 per share for the year, down from their previous forecast […]
Amgen Inc. (NASDAQ:AMGN – Free Report) – Research analysts at Cantor Fitzgerald reduced their FY2025 earnings estimates for Amgen in a research note issued to investors on Wednesday, February 5th. Cantor Fitzgerald analyst O. Brayer now forecasts that the medical research company will earn $20.67 per share for the year, down from their previous forecast […]
